Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Heron Therapeutics (HRTX)

Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Heron Therapeutics: Q3 Earnings Snapshot AP - Tue Nov 12, 7:06AM CST

Heron Therapeutics: Q3 Earnings Snapshot

HRTX : 1.5800 (+3.27%)
Heron Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 6, 4:36PM CDT

Heron Therapeutics: Q2 Earnings Snapshot

HRTX : 1.5800 (+3.27%)
Heron Therapeutics: Q1 Earnings Snapshot AP - Tue May 7, 7:06AM CDT

Heron Therapeutics: Q1 Earnings Snapshot

HRTX : 1.5800 (+3.27%)
Heron Therapeutics: Q4 Earnings Snapshot AP - Tue Mar 12, 3:34PM CDT

Heron Therapeutics: Q4 Earnings Snapshot

HRTX : 1.5800 (+3.27%)
Heron Therapeutics: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Heron Therapeutics: Q3 Earnings Snapshot

HRTX : 1.5800 (+3.27%)
Heron Therapeutics: Q2 Earnings Snapshot AP - Mon Aug 14, 2023

Heron Therapeutics: Q2 Earnings Snapshot

HRTX : 1.5800 (+3.27%)
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company focused on improving the lives of...

HRTX : 1.5800 (+3.27%)
Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 PR Newswire - Mon Aug 7, 2023

/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and...

HRTX : 1.5800 (+3.27%)
Heron Therapeutics Announces Cost Reduction Plan and Restructuring PR Newswire - Mon Jul 24, 2023

/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and...

HRTX : 1.5800 (+3.27%)
Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer PR Newswire - Fri Jun 23, 2023

/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing...

HRTX : 1.5800 (+3.27%)

Barchart Exclusives

3 Highly-Rated Dividend Stocks To Buy on the Dip Barchart - Fri Dec 20, 6:00PM CST
Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot